Reviewing Volcano (VOLC) and Viveve Medical (VIVE)

Volcano (NASDAQ: VOLC) and Viveve Medical (NASDAQ:VIVE) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Insider & Institutional Ownership

66.9% of Viveve Medical shares are owned by institutional investors. 35.1% of Viveve Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Volcano and Viveve Medical’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Volcano N/A N/A N/A ($0.74) N/A
Viveve Medical $7.14 million 13.31 -$20.11 million ($2.16) -2.26

Volcano has higher earnings, but lower revenue than Viveve Medical. Viveve Medical is trading at a lower price-to-earnings ratio than Volcano, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Volcano and Viveve Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Volcano -8.21% -10.48% -3.68%
Viveve Medical -257.58% -275.77% -102.12%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Volcano and Viveve Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Volcano 0 0 0 0 N/A
Viveve Medical 0 0 7 0 3.00

Viveve Medical has a consensus target price of $10.00, indicating a potential upside of 104.50%.

About Volcano

Volcano Corporation designs, develops, manufactures and commercializes a suite of precision guided therapy tools including intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products. The Company markets its products to physicians, nurses and technicians who perform endovascular based coronary and peripheral interventional procedures in hospitals and to other personnel who make purchasing decisions on behalf of hospitals. The Company’s products consist of consoles that are marketed as stand-alone units or as units that can be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories, or cath labs. The Company has developed customized cath lab versions of these consoles. The Company sells products directly to customers in the United States, Japan, certain European markets and South Africa. The Company’s products include consoles, IVUS products, FFR products, Pioneer plus re-entry catheter and crux VCF system.

About Viveve Medical

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician’s office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.

Receive News & Ratings for Volcano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Volcano and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit